Glucocorticoids with low-dose anti-IL1 anakinra rescue in severe non-ICU COVID-19 infection: A cohort study

BACKGROUND: The optimal treatment for patients with severe coronavirus-19 disease (COVID-19) and hyper-inflammation remains debated. MATERIAL AND METHODS: A cohort study was designed to evaluate whether a therapeutic algorithm using steroids with or without interleukin-1 antagonist (anakinra) could...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:PLoS One
Main Authors: Borie, Raphael, Savale, Laurent, Dossier, Antoine, Ghosn, Jade, Taillé, Camille, Visseaux, Benoit, Jebreen, Kamel, Diallo, Abourahmane, Tesmoingt, Chloe, Morer, Lise, Goletto, Tiphaine, Faucher, Nathalie, Hajouji, Linda, Neukirch, Catherine, Phillips, Mathilde, Stelianides, Sandrine, Bouadma, Lila, Brosseau, Solenn, Ottaviani, Sébastien, Pluvy, Johan, Le Pluart, Diane, Debray, Marie-Pierre, Raynaud-Simon, Agathe, Descamps, Diane, Khalil, Antoine, Timsit, Jean Francois, Lescure, Francois-Xavier, Descamps, Vincent, Papo, Thomas, Humbert, Marc, Crestani, Bruno, Dieude, Philippe, Vicaut, Eric, Zalcman, Gérard
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2020
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7743937/
https://ncbi.nlm.nih.gov/pubmed/33326457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0243961
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki